The acquisition will take it beyond active pharmaceutical ingredients into finished formulations and give it a licensed operating business in Germany.
Source: The Hindu – Business. Read the full story at the original publisher. Read at source
More on this topic / தொடர்புடைய செய்திகள்
- Australian banks lift interest rates
- Asian equities and US stocks futures slump amid blue sweep in US polls
- Emaar offers Dh15 a share for 100 per cent control of Emaar Development
- From waste to design: Sheikha Hind Al Qasimi’s vision for Sharjah’s creative future
- ‘Not enough energy’ for the world due to geopolitical tensions, says Ducab chief
- The Gulf is a partner, not a prize to be fought over